An investigation for investors in NASDAQ:JUNO shares was announced over potential breaches of fiduciary duties by certain officers and directors.
Investors who purchased shares of Juno Therapeutics Inc (NASDAQ:JUNO) have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain Juno Therapeutics Inc directors breached their fiduciary duties.
Juno Therapeutics Inc reported that its Net Loss increased from $243.41 million in 2014 to $239.38 million in 2015.
Shares of Juno Therapeutics Inc (NASDAQ:JUNO) declined from $68.36 per share in June 2015 to as low as $22.37 per share on February 3, 2016.
On May 12, 2016, NASDAQ:JUNO shares closed at $36.51 per share.
Those who purchased NASDAQ:JUNO shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego